• Jules Gomes

Drug giants scent gold in those transgender teens

I began peddling drugs at the age of 17. I wasn’t pushing two-bit dinky drugs like cannabis or heroin. I was into the big league. I worked for the pharmaceutical industry. After attending early-morning lectures at the University of Bombay on Wittgenstein’s aesthetics, Shakespeare’s sonnets and James Joyce’s Ulysses (you need LSD to comprehend Joyce), I’d dart off to Mumbai’s Dawa Bazaar (Medicine Market) in Princess Street and fill my bags with an assortment of drugs for my pharmacy in Mumbai’s suburbs. It was ‘open all hours’ and I was Granville to Mr Arkwright. We even had a correspondingly proportioned Nurse Gladys Emmanuel in the wings. My moment of epiphany arrived when I saw our poorest customers popping in three times a week to buy the cough syrup Benadryl. In one go, they’d down the bottle. Benadryl contained chloroform. It was far cheaper than booze. You could get inebriated on a small bottle and attain nirvana for a couple of days. It was like the plot of a John Grisham novel. Big Pharma lubricated the palms of the Food and Drug Administration to license thousands of needless new drug formulations, gave sweeties to doctors to prescribe the drugs and gave pharmacists incentives to push the pills and potions. When customers came in and stated their illness, Mr Arkwright told me that I was to sell them the brand that gave us the most commission.

It was like the plot of a John Grisham novel.

A couple of years later, I bade farewell to Mumbai’s Princess Street and joined Mumbai’s Fleet Street. My chief reporter kept yelling for exclusive stories so overnight I turned into the scourge of the multinational drug cartel. I went after multinationals such as Parke Davis, May & Baker, GlaxoSmithKline, Ciba Geigy, Pfizer, Hoechst and others who were dumping drugs in the Third World which were banned in the First World. The government appointed a commission and chloroform was banned in Benadryl. Other drugs were similarly withdrawn. Now Big Pharma has found a new ally in its old enemy, the Left. The transgender lobby is offering Big Pharma on a silver platter what would be its most lucrative market yet in the West. And Big Pharma is salivating over the big bucks it has begun raking in from children as young as nine by injecting them with puberty-postponing drugs to prepare them for sex-swap surgery. In an age of instant gratification, why wait in long NHS queues? So transgender teens are now buying hormone-altering drugs online. The NHS injects children wanting to swap their gender with the puberty blocker Gonapeptyl, costing taxpayers £82 per dose. One of its many side effects, apart from causing depression, vaginal bleeding, vomiting, hair loss, and emotional instability, is that it desensitises the pituitary gland. You can buy it online for £110.50.

Gonapeptyl is normally used to treat prostate cancer in men and reduce the size of fibroids in women or treat the formation of uterine tissue outside the uterus. Lucy Griffin, consultant psychiatrist at Bristol Royal Infirmary, has warned that doctors know very little about the long-term effects of medicines designed to delay the onset of puberty and that there is a risk of osteoporosis, permanent infertility or impaired sexual function. Not surprisingly, pharmaceutical companies in the US are contributing millions of dollars to LGBT causes. In the two-year period of 2015-2016, institutional funding for LGBTI issues globally totalled approximately $524million, a $100million increase from 2013-14. Funding specifically focused on transgender communities totalled $26.1 million. The report does not explicitly mention any pharmaceutical company in its list of donors. However, other reports reveal how Big Pharma such as Janssen Therapeutics, the health foundation of a Johnson and Johnson founder, Viiv, Pfizer, Abbott Laboratories, Bristol-Myers Squibb Company, and Boehringer Ingelheim Pharmaceuticals, are pouring big money into the transgender project.

Pharmaceutical companies in the US are contributing millions of dollars to LGBT causes.

‘This can hardly be a coincidence when the very thing absolutely essential to those transitioning are pharmaceuticals and technology,’ notes Jennifer Bilek. ‘With the medical infrastructure being built, doctors being trained for various surgeries, clinics opening at warp speed, and the media celebrating it, transgenderism is poised for growth.’ Astonishingly, transgenderism ‘sits square in the middle of the medical industrial complex, which is by some estimates even bigger than the military industrial complex,’ she concludes. We should have anticipated Big Pharma’s collusion with the LGBT lobby when Merck & Company, a Fortune 100 pharmaceutical giant, stopped funding the Boy Scouts of America because it did not permit gay adult leaders (a policy the Boy Scouts later rescinded). When I took on the drug companies in India, I knew I was taking on Big Money. And I had the anti-corporate activists and the World Health Organisation on my side. Today, anyone taking on the corporatisation of what is effectively ‘child abuse’ is taking on Big Money, Big Government and Big Ideology, perhaps the most pernicious ideology since the beginning of the sexual revolution. And this time the anti-corporate activists and the World Health Organisation are on the other side.